<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23539110</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>09</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1740-7753</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2013</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Clinical trials (London, England)</Title>
<ISOAbbreviation>Clin Trials</ISOAbbreviation>
</Journal>
<ArticleTitle>IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.</ArticleTitle>
<Pagination>
<MedlinePgn>319-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/1740774513475850</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hallmark of sickle cell disease (SCD) is pain from a vaso-occlusive crisis. Although ambulatory pain accounts for most days in pain, pain is also the most common cause of hospitalization and is typically treated with parenteral opioids. The evidence base is lacking for most analgesic practice in SCD, particularly for the optimal opioid dosing for patient-controlled analgesia (PCA), in part because of the challenges of the trial design and conduct for this rare disease.</AbstractText>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this report is to describe our Network's experiences with protocol development, implementation, and analysis, including overall study design, the value of pain assessments rather than 'crisis' resolution as trial endpoints, and alternative statistical analysis strategies.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The Improving Pain Management and Outcomes with Various Strategies (IMPROVE) PCA trial was a multisite inpatient randomized controlled trial comparing two PCA-dosing strategies in adults and children with SCD and acute pain conducted by the SCD Clinical Research Network. The specified primary endpoint was a 25-mm change in a daily average pain intensity using a Visual Analogue Scale, and a number of related pain intensity and pain interference measures were selected as secondary efficacy outcomes. A time-to-event analysis strategy was planned for the primary endpoint.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1116 individuals admitted for pain at 31 participating sites over a 6-month period, 38 were randomized and 4 withdrawn. The trial was closed early due to poor accrual, reflecting a substantial number of challenges encountered during trial implementation.</AbstractText>
<AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">While some of the design issues were unique to SCD or analgesic studies, many of the trial implementation challenges reflected the increasing complexity of conducting clinical trials in the inpatient setting with multiple care providers and evolving electronic medical record systems, particularly in the context of large urban academic medical centers.</AbstractText>
<AbstractText Label="LESSONS LEARNED" NlmCategory="CONCLUSIONS">Complicated clinical organization of many sites likely slowed study initiation. More extensive involvement of research staff and site principal investigator in the clinical care operations improved site performance. During the subsequent data analysis, alternative statistical approaches were considered, the results of which should inform future efficacy assessments and increase future trial recruitment success by allowing substantial reductions in target sample size.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A complex randomized analgesic trial was initiated within a multisite disease network seeking to provide an evidence base for clinical care. A number of design considerations were shown to be feasible in this setting, and several pain intensity and pain interference measures were shown to be sensitive to time- and treatment-related improvements. While the premature closure and small sample size precluded definitive conclusions regarding treatment efficacy, this trial furnishes a template for design and implementation considerations that should improve future SCD analgesic trials.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dampier</LastName>
<ForeName>Carlton D</ForeName>
<Initials>CD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. cdampie@emory.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Wally R</ForeName>
<Initials>WR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wager</LastName>
<ForeName>Carrie G</ForeName>
<Initials>CG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Hae-Young</ForeName>
<Initials>HY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bell</LastName>
<ForeName>Margaret C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Scott T</ForeName>
<Initials>ST</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiner</LastName>
<ForeName>Debra L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Minniti</LastName>
<ForeName>Caterina P</ForeName>
<Initials>CP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krishnamurti</LastName>
<ForeName>Lakshmanan</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ataga</LastName>
<ForeName>Kenneth I</ForeName>
<Initials>KI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Eckman</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hsu</LastName>
<ForeName>Lewis L</ForeName>
<Initials>LL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McClish</LastName>
<ForeName>Donna</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McKinlay</LastName>
<ForeName>Sonja M</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Molokie</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Osunkwo</LastName>
<ForeName>Ifeyinwa</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smith-Whitley</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Telen</LastName>
<ForeName>Marilyn J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Sickle Cell Disease Clinical Research Network (SCDCRN)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00999245</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U10 HL083705</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 HL090516</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10HL083721</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Trials</MedlineTA>
<NlmUniqueID>101197451</NlmUniqueID>
<ISSNLinking>1740-7745</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016058">Analgesia, Patient-Controlled</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000701">Analgesics, Opioid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000755">Anemia, Sickle Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015337">Multicenter Studies as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010146">Pain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059408">Pain Management</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010147">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>9</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23539110</ArticleId>
<ArticleId IdType="pii">10/2/319</ArticleId>
<ArticleId IdType="doi">10.1177/1740774513475850</ArticleId>
<ArticleId IdType="pmc">PMC5039779</ArticleId>
<ArticleId IdType="mid">NIHMS818156</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Am J Hematol. 2007 Nov;82(11):955-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17617790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2010 May;149(2):177-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20207481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Contemp Clin Trials. 2012 Mar;33(2):291-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22155024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain Med. 2010 Mar;11(3):337-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20030743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anesth Analg. 2004 Sep;99(3):699-709, table of contents</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15333398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 1991 Jul;151(7):1373-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2064488</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Epidemiol. 2008 Feb;61(2):102-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18177782</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stat Med. 1988 Nov;7(11):1195-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3201045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Acad Med Singapore. 1994 Mar;23(2):129-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8080219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Contemp Clin Trials. 2011 Sep;32(5):685-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21554992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2008 Sep;9(9):771-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18562251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2008 Jan 15;148(2):94-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18195334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Blood Cancer. 2008 Aug;51(2):265-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18386784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hemoglobin. 2007;31(4):427-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17994376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2001 Nov 7;286(17):2099-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11694150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pediatr Nurs. 1998 Feb;13(1):15-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9503762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pediatr. 2008 Feb;152(2):281-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18206703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2002 Dec;3(6):461-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14622732</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acad Emerg Med. 1996 Feb;3(2):142-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8808375</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2011 May;12(5):531-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21277838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Reg Anesth Pain Med. 2011 Jul-Aug;36(4):374-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21610560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2005 Jan;113(1-2):9-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15621359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2011 Mar 2;305(9):893-902</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21364138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anaesthesia. 1989 Jan;44(1):7-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2929911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hematol. 2012 Mar;87(3):333-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22231150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anesth Analg. 2007 Dec;105(6):1693-700, table of contents</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18042869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain. 2010 Jul;150(1):173-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20554116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biometrics. 1988 Mar;44(1):229-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3358991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2010 Nov;11(11):1095-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20452835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain. 2012 Feb;13(2):121-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22099608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stat Med. 2008 Dec 30;27(30):6612-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18816501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Trials. 2004;1(5):428-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16279281</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hematol. 2011 Dec;86(12):E70-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21953763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Haematol. 2009 Mar;144(5):782-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19055663</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Haematol. 2011 Apr;153(1):92-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21323872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1991 Jul 4;325(1):11-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1710777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anaesthesia. 1989 Jan;44(1):11-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2929900</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pediatr. 1995 Mar;126(3):461-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7869211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pain Manag. 2008;2(1):179-190</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20104257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>